Inventor

David Thomas Davies

Inventor
Harlow, GB

Overview

22→
Patents
1987–2013
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes14%
G06FElectric digital data processing4%
A01KAnimal husbandry2%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution2%
PatentTitleYear
8,584,117'Method to make SMP/E based products self describing'20138,464,246'Automation of mainframe software deployment'20138,389,524'Tricyclic nitrogen containing compounds as antibacterial agents'20138,071,592'Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones'20117,732,460'Heterocyclic compounds, their preparation and their use as antibacterials'20107,622,481'Antibacterial compounds'20097,534,793'Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity'20097,498,326'Compounds'20097,205,408'Quinolines and nitrogenated derivative thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents'20077,141,564'Nitrogen-containing bicyclic heterocycles for use as antibacterials'20067,001,913'Aminopiperidine derivatives as antibacterials'20066,962,917'Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity'20056,911,442'Quinoline derivatives as antibacterials'20056,638,953'Indole derivatives as 5-HT receptor antagonist'20036,602,882'Quinoline derivatives and their use as antibacterial agents'20036,476,028'Compounds and methods'20026,235,758'Indole derivatives as 5-HT receptor antagonist'20015,990,133'Indole derivatives as 5-HT receptor antagonist'19995,972,937'Heterocyclic compounds possessing 5HT.sub.2C receptor antagonist activity'19995,922,733'Pyridil carboxamides as 5HT2B/2C receptor antagonists'19995,447,937'CNS active tetrahydrobenzothienopyridines'19954,708,515'Stock barrier'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987Based in Pentre Halkyn, GB· patent location history
1995–2009Patents assigned to SMITHKLINE BEECHAM PLC (14)· patent assignee history
1995–2011Based in Harlow, GB· patent location history
1999–2006Based in Ware, GB· patent location history
2009–2013Patents assigned to GLAXO GROUP LTD (5)· patent assignee history
2011–2013Patents assigned to DAVIES DAVID THOMAS (2)· patent assignee history
2013Patents assigned to BMC SOFTWARE INC (2)· patent assignee history
2013Patents assigned to DAVIES DAVID (2)· patent assignee history
2013Based in Felton, CA, US· patent location history
2013Based in Stevenage, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SMITHKLINE BEECHAM PLC141995–2009
GLAXO GROUP LTD52009–2013
BMC SOFTWARE INC22013
DAVIES DAVIDself22013
DAVIES DAVID THOMASself22011–2013
Locations
LocationPatentsSpan
Harlow, GB101995–2011
Ware, GB81999–2006
Felton, California, US22013
Stevenage, GB12013
Pentre Halkyn, GB11987